BRPI0912560A2 - método de promoção da cura de feridas - Google Patents

método de promoção da cura de feridas

Info

Publication number
BRPI0912560A2
BRPI0912560A2 BRPI0912560A BRPI0912560A BRPI0912560A2 BR PI0912560 A2 BRPI0912560 A2 BR PI0912560A2 BR PI0912560 A BRPI0912560 A BR PI0912560A BR PI0912560 A BRPI0912560 A BR PI0912560A BR PI0912560 A2 BRPI0912560 A2 BR PI0912560A2
Authority
BR
Brazil
Prior art keywords
wound healing
promotion method
healing promotion
wound
promotion
Prior art date
Application number
BRPI0912560A
Other languages
English (en)
Portuguese (pt)
Inventor
R Stewart Dennis
Original Assignee
Corthera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41319048&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0912560(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corthera Inc filed Critical Corthera Inc
Publication of BRPI0912560A2 publication Critical patent/BRPI0912560A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2221—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0912560A 2008-05-16 2009-05-13 método de promoção da cura de feridas BRPI0912560A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12794708P 2008-05-16 2008-05-16
PCT/US2009/043854 WO2009140433A1 (en) 2008-05-16 2009-05-13 Method of promoting wound healing

Publications (1)

Publication Number Publication Date
BRPI0912560A2 true BRPI0912560A2 (pt) 2019-09-24

Family

ID=41319048

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912560A BRPI0912560A2 (pt) 2008-05-16 2009-05-13 método de promoção da cura de feridas

Country Status (10)

Country Link
US (2) US20100041603A1 (enExample)
EP (1) EP2278993A4 (enExample)
JP (3) JP2011520902A (enExample)
CN (2) CN105688192A (enExample)
AU (1) AU2009246333B2 (enExample)
BR (1) BRPI0912560A2 (enExample)
CA (1) CA2724308C (enExample)
MX (1) MX2010012454A (enExample)
RU (1) RU2506092C2 (enExample)
WO (1) WO2009140433A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104159594A (zh) * 2011-10-13 2014-11-19 托马斯·盖德克 用于皮肤病治疗的凯莫瑞c15肽的局部制剂
CA2878516A1 (en) * 2012-07-31 2014-02-06 Novartis Ag Treating inflammation using serelaxin
WO2015044788A1 (en) * 2013-09-26 2015-04-02 Galderma S.A. Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring
KR20180006362A (ko) * 2014-12-09 2018-01-17 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 조직 치유 및 수복을 촉진하는 방법
PT3387019T (pt) 2015-12-09 2022-01-14 Scripps Research Inst Proteínas de fusão de imunoglobulina de relaxina e métodos de uso
JP6955736B2 (ja) * 2016-09-14 2021-10-27 ヤンマーパワーテクノロジー株式会社 水生生物の飼育装置
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3003917A (en) * 1959-01-14 1961-10-10 Nat Drug Co Wound healing composition
CH661662A5 (en) * 1984-04-16 1987-08-14 Georg L Prof Dr Floersheim Product for the treatment of the skin and of the connective tissue
US4863733A (en) * 1985-08-28 1989-09-05 Startz Jack P Method of preparing treatment compositions for use in plastic or cosmetic surgery
JP2815649B2 (ja) * 1988-02-26 1998-10-27 ジェネンテク，インコーポレイテッド ヒトレラキシン製剤
US4969880A (en) * 1989-04-03 1990-11-13 Zamierowski David S Wound dressing and treatment method
US5100396A (en) * 1989-04-03 1992-03-31 Zamierowski David S Fluidic connection system and method
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
WO1996033733A1 (en) * 1995-04-25 1996-10-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel remedy for skin deficiencies
DE69624925T2 (de) * 1995-08-15 2003-09-04 Connetics Corp., Palo Alto Verwendung von relaxin zur stimulierung der angiogenese
US6176854B1 (en) * 1997-10-08 2001-01-23 Robert Roy Cone Percutaneous laser treatment
US7550143B2 (en) * 2005-04-06 2009-06-23 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
US7534866B2 (en) * 2005-10-19 2009-05-19 Ibc Pharmaceuticals, Inc. Methods and compositions for generating bioactive assemblies of increased complexity and uses
DE60128540T2 (de) * 2000-02-09 2008-01-31 Bas Medical, Inc., San Mateo Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen
AU2002324727A1 (en) * 2001-08-17 2003-03-03 The Board Of Trustees Of The Leland Stanford Junior University Mammalian relaxin receptors
CA2468826C (en) * 2001-12-07 2011-11-01 Applied Research Systems Ars Holding N.V. Benzazole derivatives for the treatment of scleroderma
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US8877901B2 (en) * 2002-12-13 2014-11-04 Immunomedics, Inc. Camptothecin-binding moiety conjugates
AU2003216375A1 (en) * 2002-02-28 2003-09-16 Immunex Corporation Rank-ligand-induced sodium/proton antiporter polypeptides
JP4959136B2 (ja) * 2002-12-13 2012-06-20 イミューノメディクス、インコーポレイテッド 細胞内で開裂可能な結合を有する免疫接合体
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor
US7738952B2 (en) * 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
US20050153885A1 (en) * 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
US8569277B2 (en) * 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
EP1846443A4 (en) * 2005-01-07 2008-07-23 Glaxo Group Ltd NEW USE
CA2604032C (en) * 2005-04-06 2017-08-22 Ibc Pharmaceuticals, Inc. Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
CN101534865A (zh) * 2005-10-19 2009-09-16 Ibc药品公司 生物活性装配体的制备方法及其用途
CN102871857A (zh) * 2005-12-15 2013-01-16 卢塞迪奥·格莱西 新型氮氧化物抗氧化剂的合成和在化妆用和皮肤病用组合物中的使用方法

Also Published As

Publication number Publication date
CN105688192A (zh) 2016-06-22
CN102026656A (zh) 2011-04-20
RU2506092C2 (ru) 2014-02-10
JP2014129392A (ja) 2014-07-10
RU2010151472A (ru) 2012-06-27
MX2010012454A (es) 2011-03-29
CA2724308A1 (en) 2009-11-19
CA2724308C (en) 2016-08-16
AU2009246333A1 (en) 2009-11-19
JP2016179990A (ja) 2016-10-13
EP2278993A1 (en) 2011-02-02
JP2011520902A (ja) 2011-07-21
US20100041603A1 (en) 2010-02-18
AU2009246333B2 (en) 2013-05-09
US20110092439A1 (en) 2011-04-21
WO2009140433A1 (en) 2009-11-19
EP2278993A4 (en) 2012-09-12

Similar Documents

Publication Publication Date Title
BRPI0912824A2 (pt) dispositivo de cura de ferida
BRPI0910259A2 (pt) métodos de tratamento de inflamação
BRPI0917675A2 (pt) compostos orgânicos para cura de ferida
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
EP3858416C0 (en) Catheter system
BRPI0917129A2 (pt) método de fabricação de fralda
PL2482859T3 (pl) Sposób sterylizacji
EP2296593A4 (en) MEDICAL HEAD COVER
BRPI0919116A2 (pt) método
BRPI0919447A2 (pt) derivados do ácido 1-amino-2-ciclobutiletilborônico
BRPI0915593A2 (pt) Curativo de ferida
BRPI0910854A2 (pt) métodos de tratamento
BRPI0912281A2 (pt) curativo de feridas
EP2442833A4 (en) Wound healing device
DE112009000964A5 (de) Tampon
DK2330887T3 (da) Behandlingsindretning
DK2313489T3 (da) Fremstillingsmetode
ATE536905T1 (de) Dilatationskatheter
FI20085657L (fi) Valaisin ja ohjausmenetelmä
EP2319712A4 (en) TIRE
BRPI0908715A2 (pt) métodos para tratamento da psoríase
IT1392897B1 (it) Frazione piastrinica derivante da sangue placentare
BRPI0914151A2 (pt) distribuidor de medicamento e método
JP2008297558A5 (ja) 重合方法
BRPI0916597A2 (pt) Método

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.